After several years of being “overlooked” as fad ingredients took the spotlight, industry attention is returning to chromium picolinate, an ingredient with dozens of clinical trials to substantiate its benefits across a range of health conditions, says...
Nutrition 21 LLC and JDS Therapeutics LLC have entered into a confidential settlement and license agreement with Schwabe North America and Nature’s Way, thereby ending a patent infringement lawsuit involving the use of chromium picolinate.
Nutrition 21 is publicizing new clinical data indicating a
positive effect of chromium picolinate on cognitive function,
the results of which look set to expand the functional profile of
A study from the Ohio State University Department of Human
Nutrition found that Nutrition 21's branded chromium picolinate is
absorbed better than other forms of the mineral linked to diabetes
Nutrition 21 has reported significant operating losses in its
second quarter after bolstering marketing expenses to support its
shift into finished products – an effort it said has paid off in
Nutrition 21 has reported sales on a par with last year in full
year 2006 and increased losses, but believes it is on the cusp of
great things for the coming year as it fully implements its shift
from ingredients to finished products...
A daily supplement of chromium picolinate, in combination with a
common anti-diabetic medication, could improve blood sugar levels
as well as cutting weight gain by 60 per cent, says a US clinical
Nutrition 21 has high hopes for the distribution of its Chromax
chromium picolinate in retail outlets, with a major marketing
planned for the summer, but the first fruit of commercialization is
yet to be seen in its financial results.
The FDA has issued a favorable response to a qualified health claim
petition filed by Nutrition 21 for the nutritional supplement
chromium picolinate, though it concluded that any link between
chromium picolinate and either insulin...
A new animal study found that Nutrition 21's Chromax did not cause
genetic damage in hamster ovary cells, providing further evidence
for the safety of the company's chromium picolinate dietary
supplement and enabling its...
The FDA has requested an extension in its review of yet another
health claims petition, for Nutrition 21's submission linking
chromium picolinate with a reduced risk of insulin resistance, type
2 diabetes and related disease,...
US firm Nutrition 21 will seek to boost sales of chromium
piocolinate in Europe, following acceptance of a scientific dossier
in the UK that gives the ingredient up to four years of derogation
from the food supplements directive,...
The first clinical trial into the effects of chromium
supplementation in children with type 1 diabetes is now underway at
the Childrens' Hospital in Los Angeles, announced Nutrition 21,
which is supplying Chromax chromium picolinate...
The maker of chromium-based supplements has reported a 12.6 percent
sales increase for the quarter ended 31 December 2004, up to $2.6
million compared with $2.3 million for the same period of last
Nutrition 21 said recently that the NIH would continue to fund
research into the benefits of chromium picolinate for sufferes of
diabetes. The company's CEO told NutraIngredientsUSA.com what this
means and her company's...
Nutrition 21 announced last week that a bill signed into law by
President George Bush recognizes the health benefits of chromium
picolinate towards diabetes and urges further research into its
Nutrition 21, specialising in chromium-based nutritional
supplements, almost halved losses in the three months to December
as it shed costs associated with its discontinued Lite-Bites
business and achieved higher pricing for its core...
Supplement manufacturer Nutrition 21 has filed a health claim
petition with the US Food and Drug Administration (FDA) for use of
eight dietary supplement health claims associating chromium
picolinate supplementation with reduced risk...
Daily supplementation with 1,000 mcg of chromium as chromium
picolinate could be used as a new nutritional therapy for
polycystic ovarian syndrome, according to results of a new pilot
study funded by the National Institutes of Health.
Chromium picolinate supplier Nutrition 21 has filed for a partial
summary judgment on its suit against InterHealth Nutraceuticals,
which it alleges uses misleading advertising for its chromium
Further independent research suggests that daily nutritional
supplementation with 1,000 mcg of chromium as chromium picolinate
can significantly decrease blood sugar levels in insulin-treated
people with poorly-controlled type 2 diabetes.
A supplement containing chromium picolinate and biotin
significantly reduced elevated blood sugar levels in people with
type 2 diabetes after only twelve weeks, reported researchers at
the International Diabetes Federation (IDF) Congress...
Chromium picolinate manufacturer Nutrition 21 reports on new
studies including a combination of chromium picolinate and CLA
found to increase muscle glycogen levels, contributing to physical
strength and endurance.
Chromium supplement maker Nutrition 21 last week reported a net
loss of $1.1 million on revenues of $3.1 million for the third
quarter, compared with a loss of $0.2 million on revenues of $4.0
million for the same period a year ago.
The dietary supplement industry has responded to last week's report
from an expert group in the UK which recommends new, "conservative"
upper safe levels for vitamins and minerals, and also advises a ban
A recent conference on chromium picolinate highlighted the evidence
backing the use of chromium in glucose control for people with type
2 diabetes and insulin resistance, suggests chromium maker